FibroBiologics, Inc. (FBLG) stock
FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.93−0.04 (-4.21%)
Close on Nov 13, 2026Market cap $6.17MP/E –Yield –
FibroBiologics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for FibroBiologics
FibroBiologics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?